Acceleron Pharma
0 sources
Financials
0001280600-21-000017Acceleron Pharma
Summary
Acceleron Pharma is a business[1]. It ranks in the top 4% of business entities by monthly Wikipedia readership (104 views/month).[2]
Key Facts
- Acceleron Pharma is in the country of United States[3].
- Acceleron Pharma is in the country of US[4].
- Acceleron Pharma's instance of is recorded as business[5].
- Acceleron Pharma's instance of is recorded as public company[6].
- Acceleron Pharma's instance of is recorded as biopharmaceutical company[7].
- Acceleron Pharma's headquarters location is recorded as Boston[8].
- Acceleron Pharma's headquarters location is recorded as Cambridge[9].
- Acceleron Pharma's stock exchange is recorded as Nasdaq[10].
- Acceleron Pharma's industry is recorded as pharmaceutical industry[11].
- 2003 marks the founding of Acceleron Pharma[12].
- Acceleron Pharma's official website is recorded as http://www.acceleron.com/[13].
- Acceleron Pharma's legal form is recorded as Delaware corporation[14].
- Acceleron Pharma's legal form is recorded as XTIQ[15].
- Acceleron Pharma's social media followers is recorded as {'amount': '+1668'}[16].
- Acceleron Pharma's social media followers is recorded as {'amount': '+1491'}[17].
Product Details
The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.
GLEIF Golden Copy — Level 1 entity data
-
Legal Entity Identifier (LEI): 529900TQRID2UY164805[18]
-
Registered legal name: Acceleron Pharma Inc.[19]
-
Legal jurisdiction: US-DE[20]
-
GLEIF entity category: GENERAL[21]
-
Legal form (ISO 20275 ELF): XTIQ[22]
-
Entity status: ACTIVE[23]
-
LEI registration status: LAPSED[24]
-
LEI first registered: 2019-02-22[25]
-
LEI last updated: 2021-07-19[26]
-
LEI next renewal: 2020-02-22[27]
-
Managing LOU: 5299000J2N45DDNE4Y28[28]
-
Registration authority: RA000602[29]
-
Authority entity ID: 3670071[30]
-
Conformity flag: NON_CONFORMING[31]
Body
Founding
2003 marks the founding of Acceleron Pharma[12].
Operations
Headquarters locations include Boston[8], a city in the United States[32], in United States[33], founded in 1630[34] and Cambridge[9], a city in the United States[35], in United States[36], founded in 1630[37].
Industry
Acceleron Pharma's industry is recorded as pharmaceutical industry[11].
Ownership
Acceleron Pharma's stock exchange is recorded as Nasdaq[10].
Why It Matters
Acceleron Pharma ranks in the top 4% of business entities by monthly Wikipedia readership (104 views/month).[2] It has Wikipedia articles in 5 language editions, a strong signal of global cultural recognition.[38]